Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer

Clinical trial NCT05872204 · RECRUITING

Trial details

NCT number: NCT05872204
Sponsor: Universitaire Ziekenhuizen KU Leuven
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Low Grade Serous Ovarian Carcinoma Adult Type Granulosa Cell Tumor

Start date: 2023-11-30
Primary completion: 2028-01-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.